Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from http://www.ncbi.nlm.nih.gov/pubmed/21714641 below:

Reduced lung-cancer mortality with low-dose computed tomographic screening

Randomized Controlled Trial

Collaborators

• PMID: 21714641
• PMCID: PMC4356534
• DOI: 10.1056/NEJMoa1102873

Item in Clipboard

Randomized Controlled Trial

National Lung Screening Trial Research Team et al. N Engl J Med. 2011.

• PMID: 21714641
• PMCID: PMC4356534
• DOI: 10.1056/NEJMoa1102873

Item in Clipboard

Background: The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening. The advent of low-dose helical computed tomography (CT) altered the landscape of lung-cancer screening, with studies indicating that low-dose CT detects many tumors at early stages. The National Lung Screening Trial (NLST) was conducted to determine whether screening with low-dose CT could reduce mortality from lung cancer.

Methods: From August 2002 through April 2004, we enrolled 53,454 persons at high risk for lung cancer at 33 U.S. medical centers. Participants were randomly assigned to undergo three annual screenings with either low-dose CT (26,722 participants) or single-view posteroanterior chest radiography (26,732). Data were collected on cases of lung cancer and deaths from lung cancer that occurred through December 31, 2009.

Results: The rate of adherence to screening was more than 90%. The rate of positive screening tests was 24.2% with low-dose CT and 6.9% with radiography over all three rounds. A total of 96.4% of the positive screening results in the low-dose CT group and 94.5% in the radiography group were false positive results. The incidence of lung cancer was 645 cases per 100,000 person-years (1060 cancers) in the low-dose CT group, as compared with 572 cases per 100,000 person-years (941 cancers) in the radiography group (rate ratio, 1.13; 95% confidence interval [CI], 1.03 to 1.23). There were 247 deaths from lung cancer per 100,000 person-years in the low-dose CT group and 309 deaths per 100,000 person-years in the radiography group, representing a relative reduction in mortality from lung cancer with low-dose CT screening of 20.0% (95% CI, 6.8 to 26.7; P=0.004). The rate of death from any cause was reduced in the low-dose CT group, as compared with the radiography group, by 6.7% (95% CI, 1.2 to 13.6; P=0.02).

Conclusions: Screening with the use of low-dose CT reduces mortality from lung cancer. (Funded by the National Cancer Institute; National Lung Screening Trial ClinicalTrials.gov number, NCT00047385.).

PubMed Disclaimer

The number…

The number of lung cancers (Panel A) includes lung cancers that were diagnosed from the date of randomization through December 31, 2009. The number of deaths from lung cancer (Panel B) includes deaths that occurred from the date of randomization through January 15, 2009.

• Better evidence about screening for lung cancer.

  Sox HC. Sox HC. N Engl J Med. 2011 Aug 4;365(5):455-7. doi: 10.1056/NEJMe1103776. Epub 2011 Jun 29. N Engl J Med. 2011. PMID: 21714644 No abstract available.

• Screening: Finding the smoking gun in lung cancer.

  Kirk R. Kirk R. Nat Rev Clin Oncol. 2011 Aug 2;8(9):510. doi: 10.1038/nrclinonc.2011.120. Nat Rev Clin Oncol. 2011. PMID: 21808271 No abstract available.

• Regelmässiges CT-Screening bei Personen mit erhöhtem Risiko reduziert Mortalität an Lungenkrebs.

  Steurer J. Steurer J. Praxis (Bern 1994). 2011 Nov 2;100(22):1377-8. doi: 10.1024/1661-8157/a000718. Praxis (Bern 1994). 2011. PMID: 22048916 German. No abstract available.

• ACP Journal Club. Screening with low-dose computed tomography reduced lung cancer mortality in high-risk patients.

  Gross CP. Gross CP. Ann Intern Med. 2011 Nov 15;155(10):JC5-06. doi: 10.7326/0003-4819-155-10-201111150-02006. Ann Intern Med. 2011. PMID: 22084353 No abstract available.

• Reduced lung-cancer mortality with CT screening.

  Patel AR, Wedzicha JA, Hurst JR. Patel AR, et al. N Engl J Med. 2011 Nov 24;365(21):2035; author reply 2037-8. doi: 10.1056/NEJMc1110293. N Engl J Med. 2011. PMID: 22111728 No abstract available.

• Reduced lung-cancer mortality with CT screening.

  Heleno B, Rasmussen JF, Brodersen J. Heleno B, et al. N Engl J Med. 2011 Nov 24;365(21):2036; author reply 2037-8. doi: 10.1056/NEJMc1110293. N Engl J Med. 2011. PMID: 22111729 No abstract available.

• Reduced lung-cancer mortality with CT screening.

  Bach PB. Bach PB. N Engl J Med. 2011 Nov 24;365(21):2036; author reply 2037-8. doi: 10.1056/NEJMc1110293. N Engl J Med. 2011. PMID: 22111730 No abstract available.

• Reduced lung-cancer mortality with CT screening.

  Kohn MA. Kohn MA. N Engl J Med. 2011 Nov 24;365(21):2036-7; author reply 2037-8. doi: 10.1056/NEJMc1110293. N Engl J Med. 2011. PMID: 22111731 No abstract available.

• Reduced lung-cancer mortality with CT screening.

  Sestini P. Sestini P. N Engl J Med. 2011 Nov 24;365(21):2037; author reply 2037-8. doi: 10.1056/NEJMc1110293. N Engl J Med. 2011. PMID: 22111732 No abstract available.

• Finding needles in a haystack: annual low-dose computed tomography screening reduces lung cancer mortality in a high-risk group.

  Duke SL, Eisen T. Duke SL, et al. Expert Rev Anticancer Ther. 2011 Dec;11(12):1833-6. doi: 10.1586/era.11.185. Expert Rev Anticancer Ther. 2011. PMID: 22117150

• Computed axial tomography scans, calories, and computers.

  Bhatt SP, Kumar G, Nassar BS. Bhatt SP, et al. Am J Respir Crit Care Med. 2012 Mar 1;185(5):584-5. doi: 10.1164/rccm.201108-1571RR. Am J Respir Crit Care Med. 2012. PMID: 22383569 No abstract available.

• Understanding the core result of the National Lung Screening Trial.

  Yankelevitz DF, Smith JP. Yankelevitz DF, et al. N Engl J Med. 2013 Apr 11;368(15):1460-1. doi: 10.1056/NEJMc1213744. N Engl J Med. 2013. PMID: 23574139 No abstract available.

• Perilous potential: the chance to save lives, or lose them, through low dose computed tomography screening for lung cancer.

  Bach PB. Bach PB. J Surg Oncol. 2013 Oct;108(5):287-8. doi: 10.1002/jso.23389. Epub 2013 Aug 27. J Surg Oncol. 2013. PMID: 23983184 No abstract available.

• A fifth of lung cancers detected by low dose CT screening are likely to be indolent, study says.

  McCarthy M. McCarthy M. BMJ. 2013 Dec 11;347:f7456. doi: 10.1136/bmj.f7456. BMJ. 2013. PMID: 24335809 No abstract available.

• [Cons: Lung cancer screening with low-dose computed tomography].

  Ruano-Ravina A, Fernández-Villar A, Provencio-Pulla M. Ruano-Ravina A, et al. Gac Sanit. 2016 Sep-Oct;30(5):383-5. doi: 10.1016/j.gaceta.2016.03.003. Epub 2016 Apr 27. Gac Sanit. 2016. PMID: 27132192 Spanish. No abstract available.

• Results of initial low-dose computed tomographic screening for lung cancer.

  National Lung Screening Trial Research Team; Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S. National Lung Screening Trial Research Team, et al. N Engl J Med. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120. N Engl J Med. 2013. PMID: 23697514 Free PMC article. Clinical Trial.

• Results of the two incidence screenings in the National Lung Screening Trial.

  Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team. Aberle DR, et al. N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962. N Engl J Med. 2013. PMID: 24004119 Free PMC article. Clinical Trial.

• Cost-effectiveness of CT screening in the National Lung Screening Trial.

  Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C; National Lung Screening Trial Research Team. Black WC, et al. N Engl J Med. 2014 Nov 6;371(19):1793-802. doi: 10.1056/NEJMoa1312547. N Engl J Med. 2014. PMID: 25372087 Free PMC article. Clinical Trial.

• Screening for lung cancer.

  Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, Campbell D. Manser R, et al. Cochrane Database Syst Rev. 2013 Jun 21;2013(6):CD001991. doi: 10.1002/14651858.CD001991.pub3. Cochrane Database Syst Rev. 2013. PMID: 23794187 Free PMC article. Review.

• Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.

  Bonney A, Malouf R, Marchal C, Manners D, Fong KM, Marshall HM, Irving LB, Manser R. Bonney A, et al. Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2. Cochrane Database Syst Rev. 2022. PMID: 35921047 Free PMC article. Review.

• Five decades of progress in surgical oncology: Tumors of the lung and esophagus.

  Rusch VW. Rusch VW. J Surg Oncol. 2022 Oct;126(5):921-925. doi: 10.1002/jso.27033. J Surg Oncol. 2022. PMID: 36087084 Free PMC article.

• Implementing Lung Cancer Screening and Prevention in Academic Centers, Affiliated Network Offices and Collaborating Care Sites.

  Presant CA, Salgia R, Kulkarni P, Tiep BL, Sanani S, Leach B, Ashing K, Sandoval J, Sedrak MS, Landau S, Yeung S, Raz D, Subbiah S. Presant CA, et al. J Clin Med. 2020 Jun 11;9(6):1820. doi: 10.3390/jcm9061820. J Clin Med. 2020. PMID: 32545244 Free PMC article.

• Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.

  Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC. Evans WK, et al. Curr Oncol. 2016 Jun;23(3):e179-87. doi: 10.3747/co.23.2988. Epub 2016 Jun 9. Curr Oncol. 2016. PMID: 27330355 Free PMC article.

• Complications of HIV disease and antiretroviral therapy.

  Luetkemeyer AF, Havlir DV, Currier JS. Luetkemeyer AF, et al. Top Antivir Med. 2012 Jun-Jul;20(2):48-60. Top Antivir Med. 2012. PMID: 22710907 Free PMC article. Review.

• Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.

  Black WC. Black WC. J Thorac Imaging. 2015 Mar;30(2):79-87. doi: 10.1097/RTI.0000000000000136. J Thorac Imaging. 2015. PMID: 25635704 Free PMC article. Review.

1. 1. Ding L, Getz G, Wheeler DA, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature. 2008;455:1069–75. - PMC - PubMed
2. 1. Sanders HR, Albitar M. Somatic mutations of signaling genes in non-small-cell lung cancer. Cancer Genet Cytogenet. 2010;203:7–15. - PubMed
3. 1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300. Erratum, CA Cancer J Clin 2011;61:133-4. - PubMed
4. 1. Cancer of the lung and bronchus (invasive): trends in SEER incidence and U.S. mortality using the Joinpoint Regression Program, 1975-2007 with up to four Join-points, 1992-2007 with up to two Join-points, both sexes by race/ethnicity. http://seer.cancer.gov/csr/1975_2007/results_merged/sect_15_lung_bronchu....
5. 1. Pierce JP, Messer K, White MM, Cowling DW, Thomas DP. Prevalence of heavy smoking in California and the United States, 1965-2007. JAMA. 2011;305:1106–12. - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3